Mystic Pharmaceuticals Appoints Gerald D. Cagle Ph.D. And Grady Rylander M.D. To Scientific Advisory Board

Mystic Pharmaceuticals, Inc., a privately held integrated specialty pharmaceutical company, announced today that Gerald D. Cagle Ph.D. and Grady Rylander M.D. have joined Mystic's Scientific Advisory Board. Dr. Cagle is the former Chief Scientific Officer and Senior Vice President of Research and Development of Alcon Laboratories, Inc. Dr. Rylander is a board certified ophthalmologist with the Eye Institute of Austin and a Professor in Biomedical Engineering at the University of Texas-Austin. 

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.